SKIN PATCHES AND SUSTAINED-RELEASE FORMULATIONS COMPRISING LOFEXIDINE FOR TRANSDERMAL AND ORAL DELIVERY

• 1. 用于卡巴拉汀经皮给药的经皮治疗系统 [P] . 中国专利： CN111093639A . 2020-05-01
• 2. 度洛西汀中间体的制备方法 [P] . 中国专利： CN113912582A . 2022-01-11
• 3. Skin Patches and Sustained-Release Formulations Comprising Lofexidine for Transdermal and Oral Delivery [P] . 美国专利： US2011097393A1 . 2011-04-28

  机译： 包含洛美替丁的皮肤贴片和缓释制剂，用于透皮和口服给药

• 4. SKIN PATCHES AND SUSTAINED-RELEASE FORMULATIONS COMPRISING LOFEXIDINE FOR TRANSDERMAL AND ORAL DELIVERY [P] . 欧洲知识产权局专利： EP2309993A1 . 2011-04-20

  机译： 洛非西汀经皮和经口给药的皮肤修补剂和缓释剂

• 5. SKIN PATCHES AND SUSTAINED-RELEASE FORMULATIONS COMPRISING LOFEXIDINE FOR TRANSDERMAL AND ORAL DELIVERY [P] . 世界知识产权组织专利： WO2009158477A1 . 2009-12-30

  机译： 洛非西汀经皮和经口给药的皮肤修补剂和缓释剂

• 1. A stepwise optimization strategy to formulate in situ gelling formulations comprising fluconazole-hydroxypropyl-beta-cyclodextrin complex loaded niosomal vesicles and Eudragit nanoparticles for enhanced antifungal activity and prolonged ocular delivery [J] . Heba Elmotasem, Ghada E.A.Awad 亚洲药物制剂科学(英文) . 2020,第005期
• 2. Zingiber cassumunar blended patches for skin application:Formulation,physicochemical properties,and in vitro studies [J] . Jirapornchai Suksaeree, Laksana Charoenchai, Fameera Madaka, 亚洲药物制剂科学(英文) . 2015,第004期
• 3. Fabrication of novel elastosomes for boosting the transdermal delivery of diacerein: statistical optimization, ex-vivo permeation, in-vivo skin deposition and pharmacokinetic assessment compared to oral formulation [J] . Diana E. Aziz, Aly A. Abdelbary, Abdelhalim I. Elassasy Drug delivery. . 2018,第1期
• 4. Predicting skin penetration of actives from complex cosmetic formulations: an evaluation of inter formulation and inter active effects during formulation optimization for transdermal delivery [J] . J. W. Wiechers, A. C. Watkinson, S. E. Cross International Journal of Cosmetic Science . 2012,第6期
• 5. Biodegradable nanoparticle based transdermal patches for gentamicin delivery: Formulation, characterization and pharmacokinetics in rabbits [J] . Bushra Akhtar, Faqir Muhammad, Bilal Aslam, Journal of drug delivery science and technology . 2020,第1期
• 6. ASSESSMENT OF HUMAN CADAVER AND RECONSTRUCTED SKIN MODELS TO PREDICT PHARMACOKINETICS OF TESTOSTERONE TRANSDERMAL DRUG DELIVERY PATCHES [C] . S.L.W. Mvszka, M.L. Husberg, J.M.Lawton, International symposium on controlled release of bioactive materials;Consumer diversified products conference . 2001
• 7. Enhanced Delivery of Actives through Skin from Patches and Formulations, and Distribution within and across Skin [D] . Puri, Ashana. 2019
• 8. Fabrication of novel elastosomes for boosting the transdermal delivery of diacerein: statistical optimization ex-vivo permeation in-vivo skin deposition and pharmacokinetic assessment compared to oral formulation [O] . Diana E. Aziz, Aly A. Abdelbary, Abdelhalim I. Elassasy 2018
• 9. Formulation and characterization of transdermal patches for controlled delivery of duloxetine hydrochloride [O] . 2016

• 1. Radio Frequency-Microchannels for Transdermal Delivery: Characterization of Skin Recovery and Delivery Window [J] . Yossi Kam ,Hagit Sacks ,Keren Mevorat Kaplan . 药理与制药（英文） . 2012,第1期
• 2. Design, Formulation and Evaluation of Transdermal Drug Delivery System of Budesonide [J] . Updesh B Lade ,Yogesh M Amgaonkar ,Rupesh V Chikhale . 药理与制药（英文） . 2011,第3期
• 3. Characteristics and pharmacokinetics of tripterygium glycosides nano-carries transdermal delivery systems:skin-blood synchronous microdialysis and numerical simulation [J] . LIU Ji-yong ,YANG Meng ,GU Yong-wei . 中国药理学与毒理学杂志 . 2016,第10期
• 4. 度洛西汀与帕罗西汀治疗首发抑郁症性功能影响研究 [C] . 费锦锋 ,戴红 ,吴杰 . 2015中国心理卫生协会老年心理卫生专业委员会第十二届年会、浙江省康复医学睡眠障碍专业委员会学术年会暨浙江省医学会精神病学分会老年精神障碍学组学术年会 . 2015
• 5. 长春西汀醇质体凝胶经皮给药载体的研究 [A] . 毛艳婷 . 2013